Holen Sie sich die Stockscreener-App
10.15
0.30%
0.03
Handel nachbörslich:
10.05
-0.10
-0.99%
Schlusskurs vom Vortag:
$10.12
Offen:
$9.96
24-Stunden-Volumen:
57,342
Relative Volume:
0.32
Marktkapitalisierung:
$201.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-52.35
EPS:
-0.1939
Netto-Cashflow:
$-44.93M
1W Leistung:
-3.33%
1M Leistung:
+9.73%
6M Leistung:
-23.68%
1J Leistung:
-55.15%
1-Tages-Spanne:
$9.94
$10.18
1-Wochen-Bereich:
$9.62
$10.50
52-Wochen-Spanne:
$6.50
$22.31
Cybin Inc Stock (CYBN) Company Profile
Firmenname
Cybin Inc
Sektor
Branche
Telefon
908 764 8385
Adresse
100 King Street West, Suite 5600, Toronto
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-11-19 | Herabstufung | Maxim Group | Buy → Hold |
Cybin Inc Aktie (CYBN) Neueste Nachrichten
Cybin, Inc.Why Compass Pathways Is No Compass for Cybin's Progression Prospects - Smartkarma
PDS Planning Inc Has $2.38 Million Stock Holdings in Cybin Inc. (NYSE:CYBN) - MarketBeat
Cybin Inc: Another High-Risk Psychedelics Play (NYSE:CYBN) - Seeking Alpha
Cybin to Participate at the 2024 Milken Institute Future of Health Summit - BioSpace
Cybin to Highlight Innovations at Health Summit - TipRanks
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
(CYBN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program - MSN
Cybin secures patent for CNS disorder treatment candidates - Investing.com
Cybin announces grant of patent in support of CYB005 phenethylamines program - TipRanks
Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Yahoo Finance UK
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Sanctuary Advisors LLC Makes New Investment in Cybin Inc. (NYSE:CYBN) - MarketBeat
Cybin (NYSE:CYBN) Trading Down 7.4%What's Next? - MarketBeat
Cybin (NYSE:CYBN) Stock Price Up 9.7%What's Next? - MarketBeat
Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha
(CYBN) Trading Signals - Stock Traders Daily
Cybin: Top Value Psychedelic Stock (NYSE:CYBN) - Seeking Alpha
Cybin (NYSE:CYBN) Shares Gap DownWhat's Next? - MarketBeat
Cybin (OTCMKTS:CYBN) Trading 1.5% HigherHere's What Happened - MarketBeat
Cybin (NYSE:CYBN) Shares Up 5.4%Still a Buy? - MarketBeat
(CYBN) Investment Analysis and Advice - Stock Traders Daily
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside Chat - MSN
Cybin Inc. CEO to Speak at Research Event - TipRanks
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 - StockTitan
Cybin (NYSE:CYBN) Trading Down 4.8% - MarketBeat
Cybin gears up for Phase 3 trial in depression treatment By Investing.com - Investing.com South Africa
Cybin gears up for Phase 3 trial in depression treatment - Investing.com
Cybin Gears Up for Global Phase 3 Depression Trial - TipRanks
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program - Yahoo Finance
Cybin (NYSE:CYBN) Shares Gap Down to $9.88 - MarketBeat
Water Tower Research Publishes Initiation of Coverage - GlobeNewswire
Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., “A Leader in Novel Neuropsychiatry Therapeutics” - Yahoo Finance
When the Price of (CYBN) Talks, People Listen - Stock Traders Daily
Cybin (NYSEAMERICAN:CYBN) Shares Down 4.4% - Defense World
Cybin Inc. (NYSEAMERICAN:CYBN) Sees Large Decline in Short Interest - Defense World
Cybin Joins Prestigious Neuropsychiatry Summit - TipRanks
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Business Wire
Ice Cube Says He's 'Never' Been to a Diddy Party After Rapper's Arrest - Us Weekly
Tilray (NASDAQ:TLRY) Shares Down 1.2% - Defense World
Cybin (NYSE:CYBN) Sees Strong Trading Volume - MarketBeat
Cybin (NYSEAMERICAN:CYBN) Sees Strong Trading Volume - Defense World
Cybin (NYSEAMERICAN:CYBN) Sees Unusually-High Trading Volume - MarketBeat
CYBN’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
‘It’s a little kinky’: Diddy shares the key elements of a ‘freak off’ in this old clip - Yahoo Entertainment
Canaccord Genuity Group Lowers Cybin (NYSE:CYBN) Price Target to $96.00 - MarketBeat
Sean ‘Diddy’ Combs Describes His Parties amid ‘Freak Offs’ Allegations in Resurfaced ‘Conan’ Interview: ‘You Need Locks on the Doors’ - Breitbart
Ice Cube Assures Fans He’s Never Been To A Diddy Party Amid “Freak-Off” Accusations - Vibe
Cybin shares target cut by Canaccord, maintains Buy rating - Investing.com
Cybin Inc (CYBN)’s stock chart: A technical perspective - US Post News
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit - NTB Kommunikasjon
Finanzdaten der Cybin Inc-Aktie (CYBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
Kapitalisierung:
|
Volumen (24h):